Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies.

Zhao, Dong; Zhu, Dantong; Cai, Fei; Jiang, Mingzhe; Liu, Xuefei; Li, Tingting; Zheng, Zhendong

Zhao, Dong; Zhu, Dantong; Cai, Fei; Jiang, Mingzhe; Liu, Xuefei; Li, Tingting; Zheng, Zhendong.

Afiliación

Zhao D; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Zhu D; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Cai F; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Jiang M; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Liu X; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Li T; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Zheng Z; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.

Technol Cancer Res Treat ; 22: 15330338231204198, 2023.

Article en En | MEDLINE | ID: mdl-38037341

Asunto(s)

Neoplasias; Receptores Quiméricos de Antígenos; Humanos; Inmunoterapia Adoptiva/efectos adversos; Inmunoterapia Adoptiva/métodos; Receptores Quiméricos de Antígenos/genética; Linfocitos T; Receptores de Antígenos de Linfocitos T; Inmunoterapia

Palabras clave

CAR-NK; CAR-T; CAR-macrophage; TCR-T; TIL; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Neoplasias Límite: Humans Idioma: En Revista: Technol Cancer Res Treat Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google